ACTRN12605000138684已完成3 期
Phase III, randomised, intergroup, international trial assessing the clinical activity of STI571 at two dose levels in patients with unresectable or metastatic gastrointestional stromal tumors (GIST) expressing the kit receptor tyrosine kinase (CD117)
ovartis Australia0 个研究点目标入组 946 人开始时间: 2005年8月12日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 946
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •1. Documented diagnosis of GIST with kit expression. 2. At lease one measureable or evaluable site of disease. 3. Performance status 0,1,2 or 3 (ECOG).
排除标准
- •1.Patient has received chemotherapy or any other investigational agent within in last 28 days 2. Patient with Grade III/IV cardiac problems 3. Known brain metastasis
研究者
相似试验
招募中
3 期
Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating AgentD46Myelodysplastic syndromesDRKS00011259Onconova Therapeutics, Inc.225
进行中（未招募）
不适用
Phase III, multicenter, international, randomized, partial double-blind, placebo-controlled study to evaluate the efficacy and safety of alfimeprase in subjects with acute peripheral arterial occlusion (NAPA-2)EUCTR2004-002950-67-ITVELO
已完成
3 期
BI 10773 add-on to Usual Care Compared With Usual Care Alone in Patients With Type 2 Diabetes Mellitus at High Cardiovascular RiskCardiovascular RiskCTRI/2011/05/001725Boehringer Ingelheim Pharmaceuticals4,000
进行中（未招募）
不适用
Immunogenicity, safety and reactogenicity study of GlaxoSmithKline (GSK) Biologicals’ Hib-MenCY-TT vaccine compared to monovalent Hib vaccine in healthy infants at 2, 4, 6, and 12 to 15 months of age.Invasive disease caused by Haemophilus type b and Neisseria meningitidis serogroups C and YMedDRA version: 18.0Level: LLTClassification code 10028910Term: Neisseria meningitides meningitisSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10051931Term: Neisseria infection NOSSystem Organ Class: 100000004862EUCTR2005-002352-18-Outside-EU/EEAGlaxoSmithKline Biologicals4,441
进行中（未招募）
1 期
Controlled trial to evaluatethe efficacy and safety of glepaglutide in patients with short bowel syndromeShort bowel syndromeMedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-004394-14-GBZealand Pharma A/S129